Also Included In: Depression; Anxiety / Stress; Mental Health
Article Date: 18 Nov 2011 - 0:00 PST
email to a friend
printer friendly
opinions 

New research identifies the brain chemicals and circuits involved in mental illnesses like schizophrenia, depression, and anxiety, giving potential new directions to their treatment. In addition, research with children shows that early-life depression and anxiety changes the structure of the developing brain. The findings were presented at Neuroscience 2011, the Society for Neuroscience's annual meeting and the world's largest source of emerging news about brain science and health.
One in 17 Americans suffer from a serious mental illness, such as schizophrenia, major depression, or bipolar disorder, making it one of the leading causes of disability. Yet science is only beginning to understand the underlying physical causes of these diseases.
The new findings show: Childhood anxiety and depression alter the way the amygdala connects to other regions of the brain. This finding may help explain how early life stress can lead to future emotional and behavioral issues (Shaozheng Qin, PhD, abstract 927.06). In animal studies, a link between two factors associated with schizophrenia, prenatal infection and impaired function of a molecule important in memory (Melissa Burt, abstract 763.11). Researchers have identified a brain chemical important to antidepressant response in mice. The findings may help in the design of therapies for major depression (Maha Elsayed, abstract 904.10). The connections between two specific areas of the brain - the prefrontal cortex and the dorsal raphe nucleus - may contribute to depression. Stimulating these circuits in rats had an antidepressant effect (Melissa Warden, PhD, abstract 306.15). An enzyme called STEP is elevated in the brains of people with schizophrenia. Mice lacking this chemical did not develop schizophrenia-like behaviors (Nikisha Carty, PhD, abstract 238.03). "If we can fully understand the roots of mental illness in brain circuitry and systems, we may be able to develop better treatment targets for the millions suffering from these diseases," said press conference moderator Carol Tamminga, MD, of the University of Texas Southwestern, who is an expert on schizophrenia. Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our schizophrenia section for the latest news on this subject. This research was supported by national funding agencies, such as the National Institutes of Health, as well as private and philanthropic organizations.
Full release
Society for Neuroscience Please use one of the following formats to cite this article in your essay, paper or report:
MLA
9 Dec. 2011.
Please note: If no author information is provided, the source is cited instead.
posted by sdc on 4 Dec 2011 at 1:09 am
It's not necessarily enough to develop better targeted antidepressants (I don't know about antipsychotics). They need to be far more effective than they currently mostly are. So what if they learn to target antidepressants better, if their end results remain the same, i.e partial responses with a bunch of depressives symptoms remaining. This field seems to be moving too slowly, already. It's not as if depression was discovered recently. They still talk about it like they did of HIV/AIDS when it was discovered some decades ago (yet that disease can already be controlled).
| post followup | alert a moderator |
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.